cerevisiae production strains
10.2.4.2 Doses, Associations, and Efficacy When used as monotherapy, they reduce hemoglobin HbA1c percentage between 0.8 and 1.5 %, showing the same potency as that of metformin Thiazolidinediones could be administered as monotherapy or in combination with complementary antidiabetic drugs such as metformin, sulfonylureas, meglitinides, incretin mimetics, and DPP4 inhibitors
The treatment is named after its special formulation, which includes natural compounds known to promote fat breakdown
doi: 10.1016/j.toxicon.2021.09.002 Nixon, Samantha A., Robinson, Samuel D., Agwa, Akello J., Walker, Andrew A., Choudhary, Shivani, Touchard, Axel, Undheim, Eivind A.B., Robertson, Alan, Vetter, Irina, Schroeder, Christina I., Kotze, Andrew C., Herzig, Volker and King, Glenn F
Neurobiological Mechanisms of ECT and TMS Treatment in Depression: Study Protocol of a Multimodal Magnetic Resonance Investigation